Healthcare Industry News’ Post

💡 The stem cell manufacturing market is booming! Download a PDF Brochure: https://lnkd.in/gYCy33R4 According to a new research study: 🔺 The global market is estimated to be worth $12.7B in 2023 🚀 And projected to reach $21.8B by 2028, growing at a CAGR of 11.3% Key drivers fueling this growth: ✅ Rising awareness of stem cell products in clinical applications  ✅ Technical advancements in manufacturing processes However, stringent regulations remain a restraint on faster market expansion. The consumables segment dominates the product category, driven by increasing demand for regenerative therapies. Pharma & biotech firms are the leading end-users, leveraging stem cells for pioneering therapies. North America currently leads the regional market, benefiting from robust research infrastructure and a supportive regulatory environment. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: RoosterBio Inc. Garuda Therapeutics Gene and Cell Therapy Network Lykan Bioscience - Now RoslinCT PBS Biotech xcellbio Sana Biotechnology, Inc. Cell Culture Technologies Applied StemCell CGT Global Orca Bio Kytopen PeproTech Laurus Bio Trailhead Biosystems TreeFrog Therapeutics CCRM iBET - Instituto de Biologia Experimental e Tecnológica Yashraj Biotechnology Ltd ImmuneBridge  InVitria, Inc. RoslinCT  StemoniX  Mesoblast Limited  ESCO ASTER PTE LTD Society for Biological Engineering (SBE-VIT) REPROCELL HemaCare Corporation, a Charles River Company DSS Takara Bio India Pvt Ltd Histocell. Regenerative Medicine NecstGen Pluristyx, Inc. Biotron Healthcare (India) Pvt. Ltd Bonus Biogroup Sartorius CellGenix GmbH VivaBioCell  MaaT Pharma Cytovia Therapeutics  BioStem Technologies (OTC: BSEM)  C3i With surging investment and breakthrough innovations, the stem cell manufacturing landscape is ripe with opportunity! #StemCells #Regenerative #Manufacturing #Biotech #MarketResearch #StemCellManufacturing #StemCellManufacturingmarket #StemCellManufacturingmarketsize #StemCellManufacturingmarketshare #StemCellManufacturingmarkettrends

2029 𝐂𝐞𝐥𝐥 𝐈𝐬𝐨𝐥𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞, 𝐚𝐧𝐝 𝐓𝐫𝐞𝐧𝐝𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 Download PDF Brochure @ https://lnkd.in/dBw3qrKM The 𝐜𝐞𝐥𝐥 𝐢𝐬𝐨𝐥𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞 𝐚 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐨𝐟 𝐔𝐒𝐃 8.4 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐰𝐢𝐭𝐡 𝐚 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐨𝐟 𝐔𝐒𝐃 4.6 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐭𝐨 𝐫𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 12.9%. Cell isolation is mostly used to create new cell therapies and other cell-based treatments. Because of the importance of cell-based research, various government organizations around the world have increased their support for such programs. For example, in June 2024, the 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐭𝐢𝐭𝐮𝐭𝐞 𝐨𝐟 𝐍𝐞𝐮𝐫𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬 𝐚𝐧𝐝 𝐒𝐭𝐫𝐨𝐤𝐞 awarded the University of Buffalo scientists a five-year grant of approximately USD 2.9 million for a research project aimed at developing a new technology that could improve #stemcelltherapies for multiple sclerosis (MS) and other #neurologicaldiseases. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Cell Applications, Inc. Cell Microsystems CellSEP | Cell Isolation and Analytics      Namocell      Applied Cells Cellenion     Cancer Research - 3B´s    BIOMEX      SEED Biosciences      Abnova      Microbify GmbH      TdB Labs AB      Hortman Stem Cell Laboratory      Nuffield Department of Surgical Sciences - University of Oxford      Owl biomedical, Inc.  Aenitis Technologies      AVIVA Biosciences      Novabiosis, Inc.      Curiosis      Quad Technologies      Abiel      Koek Biotech      PPA Research Group      VYCAP      Adistem Ltd      L2P Research Labs      BioCep      MiCareo, Inc.      NeuroInDx, Inc.      Crescent Chemical Co., Inc      SCM Lifescience     Telomerix Stem Cell Biobank      Idaho Veterans Research and Education Foundation (IVREF)      FerroBio Technologies    Miracell Co., Ltd.,   Vetbiologics      Unhwa Life Corporation      VITROLOGIC, INC 

Regenerative Medicine Market worth $49.0 billion by 2028 📚 𝐃𝐨𝐧'𝐭 𝐦𝐢𝐬𝐬 𝐨𝐮𝐭! 𝐆𝐫𝐚𝐛 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:- https://lnkd.in/dCW82q7w 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐫𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐦𝐚𝐫𝐤𝐞𝐭, 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $16.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2023, 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $49.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2028, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 25.1%. This growth is driven by a focus on personalized medicine, increased partnerships, expanded therapeutic areas, and more regulatory approvals. #NorthAmerica dominated the global market with the highest market share. Rising investments in tissue engineering, stem cell banking, and drug discovery, coupled with an expanding healthcare sector and high adoption of cell immunotherapies for cancer and chronic diseases and stem cell therapy, are driving the North American market's robust growth. 𝐓𝐨𝐩 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐰𝐨𝐫𝐤𝐢𝐧𝐠 𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 Tissue Regenix Group         Biogenuix Medsystems Pvt Ltd         HebeCell Corp         Liquivida         Merakris Therapeutics, Inc.         Rohto-Mentholatum (VN)         Cancer Research - 3B´s      PT Prodia StemCell Indonesia         KLISBio         Vidacel         Merrick Biotech         Qkine         Kimera Labs Inc         Fluicell         PL BioScience GmbH         RegMed XB         Future Science Group         UCLA Broad Stem Cell Research Center         Orthocell Ltd         Athenaeum Scientific Publishers         Avay Biosciences         BioGrademy         AMSBIO         Cellphire Therapeutics, Inc.         Morphocell Technologies         Stempeutics Research Private Limited         Donnelly Centre for Cellular and Biomolecular Research, University of Toronto         ClexBio         Acorn Biolabs         Xintela AB         Gallant Therapeutics         Myo Palate         Department of Physiology, Anatomy & Genetics - University of Oxford         National Center for Cell Science         LongevityTech.fund         Angelantoni Life Science S.r.l.         BPB MEDICA™         3d.FAB platform         Universal Cells         curasan AG    

Who are the stem cell players that matter? ✨ Over the years the stem cell therapy market has gained traction and is valued at $12.4 billion in 2024 and is expected to reach $18.5 billion by 2029. With the increasing incidence of chronic and degenerative diseases, demand for stem cell treatment with reparative and regenerative properties is high. 🧬 The development of induced pluripotent stem cells and mesenchymal stem cells has allowed the creation of off-the-shelf cell therapies, more accessible and scalable. 📈 In this article, we delve into the companies to know about in this evolving field! ⬇️ https://lnkd.in/d2wD83QS #stemcelltherapy #regenerativemedicine #biotech #healthcareinnovation #chronicdiseases #degenerativediseases #celltherapy #biotechcompanies #stemcellresearch #medicalinnovation Aspen Neuroscience, Inc. | BlueRock Therapeutics | Cellino | Fate Therapeutics Inc. | Garuda Therapeutics | Mesoblast Limited | Orca Bio | Sana Biotechnology, Inc.

𝐂𝐞𝐥𝐥 𝐂𝐮𝐥𝐭𝐮𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $57.9 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029 Download PDF Brochure @ https://lnkd.in/dXGMxuhr The report "𝐂𝐞𝐥𝐥 𝐂𝐮𝐥𝐭𝐮𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 (𝐂𝐨𝐧𝐬𝐮𝐦𝐚𝐛𝐥𝐞𝐬 (𝐌𝐞𝐝𝐢𝐚, 𝐒𝐞𝐫𝐚, 𝐑𝐞𝐚𝐠𝐞𝐧𝐭𝐬), 𝐕𝐞𝐬𝐬𝐞𝐥𝐬 (𝐑𝐨𝐥𝐥𝐞𝐫 𝐁𝐨𝐭𝐭𝐥𝐞, 𝐂𝐞𝐥𝐥 𝐅𝐚𝐜𝐭𝐨𝐫𝐲, 𝐅𝐥𝐚𝐬𝐤), 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 (𝐒𝐔 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫, 𝐒𝐭𝐨𝐫𝐚𝐠𝐞, 𝐈𝐧𝐜𝐮𝐛𝐚𝐭𝐨𝐫𝐬, 𝐅𝐢𝐥𝐭𝐫𝐚𝐭𝐢𝐨𝐧)), 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 (𝐦𝐀𝐛𝐬, 𝐕𝐚𝐜𝐜𝐢𝐧𝐞𝐬, 𝐑𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞) - 𝐆𝐥𝐨𝐛𝐚𝐥 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 2029", is projected to reach USD 57.9 billion by 2029 from an estimated USD 30.9 billion in 2024, at a CAGR of 13.4% Cell culture plays an important role in developing products to #combatdiseases such as #cancer and #cardiovascular conditions. Globally, significant research efforts supported by government and private organizations are focused on pioneering cell therapy solutions. For example, 𝐂𝐞𝐥𝐥𝐕𝐨𝐯𝐚𝐧𝐭, a company associated with the 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐨𝐟 𝐁𝐫𝐢𝐬𝐭𝐨𝐥 received USD 9.55 million (GBP 7.6 million) in seed funding in January 2021 to expedite the development of stem cell therapies. Furthermore, collaborations between private sectors are propelling progress; notable instances include support from organizations like the Ovarian Cancer 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐀𝐥𝐥𝐢𝐚𝐧𝐜𝐞 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥 for exploring stem cell based treatments, for various illnesses. The cell therapy market is expected to experience growth due to the rising focus and investment for treating neurological and cardiovascular conditions. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Cell X Technologies Emulate, Inc. FUJIFILM Irvine Scientific Laguna Source GALY InvivoGen PBS Biotech TheWell Bioscience Visikol ScienCell Research Laboratories GBI Bio ScaleReady Chanshow Biotechnology Inc STEMCELL Technologies GeminiBio Premas Biotech Laurus Bio Trailhead Biosystems VIRCELL S.L. CuriRx, Inc GenIbet Biopharmaceuticals BioLamina ARTeSYN, A Repligen Company ProBioGen AG PT GeneCraft Labs Therapure Biopharma Inc Bioscience Institute LFB Biomanufacturing Ronawk BioIVT EPISKIN SA Xcellogen Biotech India Pvt Ltd REPROCELL T&L Biotechnology Multus Starlab Tarsons Products Limited Celltheon Corporation INFORS HT

𝐑𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $49.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2028 Download PDF Brochure @ https://lnkd.in/dPnCniRW The global 𝐫𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐦𝐚𝐫𝐤𝐞𝐭, 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $16.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2023, 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $49.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2028, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 25.1%. The global market is expected to benefit from the focus on #personalizedmedicines. Precision medicine is an approach to medical treatment that tailors therapeutics, and interventions for individual patients or a subpopulation based on their unique genetic, environmental, and lifestyle characteristics. the 𝐅𝐃𝐀 𝐚𝐩𝐩𝐫𝐨𝐯𝐞𝐝 12 𝐩𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐦𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬, 𝐫𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐢𝐧𝐠 𝐚𝐩𝐩𝐫𝐨𝐱𝐢𝐦𝐚𝐭𝐞𝐥𝐲 34% of all newly approved therapeutic molecular entities. Personalized treatments account for at least a quarter of new drug approvals since 2015. Moreover, five new gene or #cellbased therapies were approved in 2022. These include treatment of rare #geneticdisorders with few other treatment options – #betathalassemia, #hemophiliaB, and cerebral adrenoleukodystrophy, refractory multiple #myeloma, and certain types of non-muscle invasive #bladdercancer. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Stem Cell Network      BRINTER     Medicon Village      TEI Biosciences Inc      REGROW BIOSCIENCES      Longeveron Inc      HUB Organoids      CollPlant     Pandorum Technologies      Dynasty Clinic        APEX Biologix      Virtue Labs LLC      REGEMAT 3D      HTL Biotechnology      Nava Healthcare      Mogrify      Wyss Zurich      Centro de Investigación Príncipe Felipe (CIPF)      Cell Therapies Pty Ltd      International Stem Cell Corporation      Pluristyx, Inc.      Resolution Therapeutics      Walking Fish Therapeutics, Inc.      Elixirgen Scientific      Stemmatters      CUTISS AG     GENYO. Pfizer-University of Granada-Junta de Andalucia Center for Genomics and Oncological Research     Geistlich Pharma North America, Inc.      Lankenau Institute for Medical Research      REPROCELL      Foldink     Brainstorm Cell Therapeutics      Parametrics Medical      Farmaceutici Damor S.p.A.      Empire Medical Training

The global stem cell manufacturing market in terms of revenue was estimated to be worth $12.7 billion in 2023 and is poised to reach $21.8 billion by 2028, growing at a CAGR of 11.3% from 2023 to 2028. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐚𝐭 https://lnkd.in/d-KbXnRJ Recent Developments of Stem Cell Manufacturing Industry: - In April 2023, U.S. Food and Drug Administration approved Omisirge (omidubicel), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. Developments like this are increasing the demand for stem cell therapies and culture media. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Biogenuix Medsystems Pvt Ltd       Takara Bio Europe        uFluidix       OmniBRx Biotechnologies Inc. USA        Diamyd Medical       Cellistic  INGECELL AIVITA Biomedical, Inc.        Tissue Culture Biologicals        BioMagnetic Solutions        Biological Industries Sartorius        Cellex Cell Professionals        SmartCella Holding AB        Eska Pharma GmbH        3D Biotek, LLC        Cedars-Sinai Biomanufacturing Center       Axent Biosciences        Esco South Africa       Kadimastem Ltd.        Xintela AB     trenzyme GmbH        Gallant Therapeutics     Captivate Bio   Cellin Technologies        Stemedica Cell Technologies, Inc       Secondcell Bio       EmCyte Corporation®        Waisman Biomanufacturing        Neuroplast Tempo Bioscience        CytoHub, Inc.        IRBM      EquiCord       HemostOD       In vitro Plant-tech AB      #stemcellmanufacturingmarket #stemcellmanufacturing

𝐂𝐞𝐥𝐥 𝐂𝐮𝐥𝐭𝐮𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $57.9 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029 Download PDF Brochure @ https://lnkd.in/dXGMxuhr The report "𝐂𝐞𝐥𝐥 𝐂𝐮𝐥𝐭𝐮𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 (𝐂𝐨𝐧𝐬𝐮𝐦𝐚𝐛𝐥𝐞𝐬 (𝐌𝐞𝐝𝐢𝐚, 𝐒𝐞𝐫𝐚, 𝐑𝐞𝐚𝐠𝐞𝐧𝐭𝐬), 𝐕𝐞𝐬𝐬𝐞𝐥𝐬 (𝐑𝐨𝐥𝐥𝐞𝐫 𝐁𝐨𝐭𝐭𝐥𝐞, 𝐂𝐞𝐥𝐥 𝐅𝐚𝐜𝐭𝐨𝐫𝐲, 𝐅𝐥𝐚𝐬𝐤), 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 (𝐒𝐔 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫, 𝐒𝐭𝐨𝐫𝐚𝐠𝐞, 𝐈𝐧𝐜𝐮𝐛𝐚𝐭𝐨𝐫𝐬, 𝐅𝐢𝐥𝐭𝐫𝐚𝐭𝐢𝐨𝐧)), 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 (𝐦𝐀𝐛𝐬, 𝐕𝐚𝐜𝐜𝐢𝐧𝐞𝐬, 𝐑𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞) - 𝐆𝐥𝐨𝐛𝐚𝐥 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 2029", is projected to reach USD 57.9 billion by 2029 from an estimated USD 30.9 billion in 2024, at a CAGR of 13.4% Cell culture plays an important role in developing products to #combatdiseases such as #cancer and #cardiovascular conditions. Globally, significant research efforts supported by government and private organizations are focused on pioneering cell therapy solutions. For example, 𝐂𝐞𝐥𝐥𝐕𝐨𝐯𝐚𝐧𝐭, a company associated with the 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐨𝐟 𝐁𝐫𝐢𝐬𝐭𝐨𝐥 received USD 9.55 million (GBP 7.6 million) in seed funding in January 2021 to expedite the development of stem cell therapies. Furthermore, collaborations between private sectors are propelling progress; notable instances include support from organizations like the Ovarian Cancer 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐀𝐥𝐥𝐢𝐚𝐧𝐜𝐞 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥 for exploring stem cell based treatments, for various illnesses. The cell therapy market is expected to experience growth due to the rising focus and investment for treating neurological and cardiovascular conditions. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: StemBioSys, Inc. CBQF - Centre for Biotechnology and Fine Chemistry Medikonia Corning LifeScience faCellitate OmicScouts Clinbiocare Technology PELOBiotech GmbH BioNet l Genetically Designed Vaccines Capricorn Scientific GmbH Expression Systems OLS OMNI Life Science Athens Research & Technology InVivo BioTech Services GmbH - a Bruker Company Cyprio Excel Scientific, Inc. Stemina Biomarker Discovery, Inc. Ajinomoto CELLiST Korea Co., Inc. Bothwell Engineering Inc. Cryo Bio System ScreenCell Redbud Labs CYTENA BPS AIB Life Science Private Limited UGA Biopharma GmbH PAN-Biotech GmbH ZenBio NEST Scientific USA Helix Biosciences Wuxi NEST Biotechnology Co.,Ltd. Causeway Sensors Limited AppliChem Wuhan Servicebio Technology Co., Ltd. Serana Europe GmbH MEPSGEN Alkali Scientific (ASI) United States Biological Inc SciGen Ltd., Singapore Quality Biological, Inc.

𝐂𝐞𝐥𝐥 𝐂𝐮𝐥𝐭𝐮𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $57.9 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029 Download PDF Brochure @ https://lnkd.in/dXGMxuhr The report "𝐂𝐞𝐥𝐥 𝐂𝐮𝐥𝐭𝐮𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 (𝐂𝐨𝐧𝐬𝐮𝐦𝐚𝐛𝐥𝐞𝐬 (𝐌𝐞𝐝𝐢𝐚, 𝐒𝐞𝐫𝐚, 𝐑𝐞𝐚𝐠𝐞𝐧𝐭𝐬), 𝐕𝐞𝐬𝐬𝐞𝐥𝐬 (𝐑𝐨𝐥𝐥𝐞𝐫 𝐁𝐨𝐭𝐭𝐥𝐞, 𝐂𝐞𝐥𝐥 𝐅𝐚𝐜𝐭𝐨𝐫𝐲, 𝐅𝐥𝐚𝐬𝐤), 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 (𝐒𝐔 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫, 𝐒𝐭𝐨𝐫𝐚𝐠𝐞, 𝐈𝐧𝐜𝐮𝐛𝐚𝐭𝐨𝐫𝐬, 𝐅𝐢𝐥𝐭𝐫𝐚𝐭𝐢𝐨𝐧)), 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 (𝐦𝐀𝐛𝐬, 𝐕𝐚𝐜𝐜𝐢𝐧𝐞𝐬, 𝐑𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞) - 𝐆𝐥𝐨𝐛𝐚𝐥 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 2029", is projected to reach USD 57.9 billion by 2029 from an estimated USD 30.9 billion in 2024, at a CAGR of 13.4% Cell culture plays an important role in developing products to #combatdiseases such as #cancer and #cardiovascular conditions. Globally, significant research efforts supported by government and private organizations are focused on pioneering cell therapy solutions. For example, 𝐂𝐞𝐥𝐥𝐕𝐨𝐯𝐚𝐧𝐭, a company associated with the 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐨𝐟 𝐁𝐫𝐢𝐬𝐭𝐨𝐥 received USD 9.55 million (GBP 7.6 million) in seed funding in January 2021 to expedite the development of stem cell therapies. Furthermore, collaborations between private sectors are propelling progress; notable instances include support from organizations like the Ovarian Cancer 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐀𝐥𝐥𝐢𝐚𝐧𝐜𝐞 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥 for exploring stem cell based treatments, for various illnesses. The cell therapy market is expected to experience growth due to the rising focus and investment for treating neurological and cardiovascular conditions. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Wilson Wolf Manufacturing, LLC 4Dcell Life Length Mediatech Sartorius CellGenix GmbH Lucid Scientific FC-BIOS Great Bay Bio 大湾生物 Cherry Biotech PromoCell Qureator CellRev CelVivo LABCLINICS, S.A GeneX India Bioscience Pvt Ltd Nu-Tek BioSciences Qkine OmniBRx Biotechnologies Pvt Ltd BioHarvest Sciences AMSBIO Boston Institute of Biotechnology, LLC Florabio A.Ş. Ovizio Peky Biotech SYNENTEC Green Bioactives Polyclone Bioservices Phase Holographic Imaging microLIQUID Stemgent BioXpedia A/S Proliant Health & Biologicals Solentim BioNordika Denmark A/S Finesse Solutions RADOBIO SCIENTIFIC CO.,LTD Biowest Silantes GmbH Proteome Sciences plc